:: Library Catalog

Obálka

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Mamoor, Shahan
Médium:	Recurso digital
Jazyk:
Vydáno:	Zenodo 2025
On-line přístup:	https://doi.org/10.5281/zenodo.14791007
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky

NLR family genes influence homeobox transcription factor expression.
Autor: Mamoor, Shahan
Vydáno: (2025)

Glucocorticoid resistance features changes in general transcription factor (GTF) expression.
Autor: Mamoor, Shahan
Vydáno: (2025)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
Autor: Mamoor, Shahan
Vydáno: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
Autor: Mamoor, Shahan
Vydáno: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
Autor: Mamoor, Shahan
Vydáno: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
Autor: Mamoor, Shahan
Vydáno: (2025)

Androgen signaling has functions in lineage commitment in the human embryo.
Autor: Mamoor, Shahan
Vydáno: (2026)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
Autor: Mamoor, Shahan
Vydáno: (2025)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
Autor: Mamoor, Shahan
Vydáno: (2025)

Nuclear factors that govern endotoxin tolerance in the myeloid lineage.
Autor: Mamoor, Shahan
Vydáno: (2025)

MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.
Autor: Mamoor, Shahan
Vydáno: (2025)

Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
Autor: Mamoor, Shahan
Vydáno: (2025)

NLRP7 engagement in transformation and etiology of chronic disease.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
Autor: Mamoor, Shahan
Vydáno: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
Autor: Mamoor, Shahan
Vydáno: (2025)

Importin 8 is activated in childhood brain cancer.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
Autor: Mamoor, Shahan
Vydáno: (2025)

Telomerase control of Xist through Trf2.
Autor: Mamoor, Shahan
Vydáno: (2025)

Phosphatase targeting in Luminal B breast cancer: PGP.
Autor: Mamoor, Shahan
Vydáno: (2025)

Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
Autor: Mamoor, Shahan
Vydáno: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
Autor: Mamoor, Shahan
Vydáno: (2025)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SRC.
Autor: Mamoor, Shahan
Vydáno: (2025)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
Autor: Mamoor, Shahan
Vydáno: (2025)

HSC, CMP and CLP in mice.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: NFATC1.
Autor: Mamoor, Shahan
Vydáno: (2025)

Aire is a component gene of the Th17 gene signature.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GDF5.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: INPP5F.
Autor: Mamoor, Shahan
Vydáno: (2025)

A comprehensive description of the circulating tumor cell: TM6SF1.
Autor: Mamoor, Shahan
Vydáno: (2025)

FCGRT functions in senescence and transformation.
Autor: Mamoor, Shahan
Vydáno: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
Autor: Mamoor, Shahan
Vydáno: (2025)

Leukotriene activation in the blood of humans with high CRP.
Autor: Mamoor, Shahan
Vydáno: (2025)

TSC22D4 gene activation in Crohn's Disease.
Autor: Mamoor, Shahan
Vydáno: (2025)

Genes expressed in the CD4 + T lymphocyte.
Autor: Mamoor, Shahan
Vydáno: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: ATG13.
Autor: Mamoor, Shahan
Vydáno: (2025)